Ligand validation:2CVV

ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER

ANP is a Ligand Of Interest in 2CVV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2CVV_ANP_A_1001	88%	14%	0.095	0.971	1.37	2.42	4	13	0	0	100%	1
2CVU_ANP_A_1001	80%	13%	0.116	0.964	1.57	2.38	5	11	1	0	100%	1
3S8C_ANP_A_889	74%	12%	0.125	0.954	1.85	2.19	6	6	0	0	100%	1
2EUD_ANP_A_890	69%	16%	0.141	0.956	2	1.69	9	6	4	0	100%	1
2CVT_ANP_A_890	63%	9%	0.147	0.942	1.53	2.83	4	9	3	0	100%	1
3S8B_ANP_A_890	57%	16%	0.153	0.929	1.75	1.91	6	6	5	1	100%	1
8PS7_ANP_A_704	100%	43%	0.023	0.994	1.15	1.05	4	2	0	0	100%	1
9AVR_ANP_A_501	100%	36%	0.034	0.991	1.05	1.46	2	5	2	0	100%	1
4BRA_ANP_A_1394	100%	12%	0.037	0.993	2.3	1.8	10	6	3	0	100%	1
4DFX_ANP_E_402	100%	32%	0.036	0.989	1.35	1.35	4	2	1	0	100%	1
4BRD_ANP_B_1396	100%	16%	0.041	0.994	1.66	2.04	4	10	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.